Cardiac allotransplantation is now an established therapeutic modality for end-stage heart disease (1). Although the operative procedure remains essentially unchanged, recent advances in mechanical assist technology and significant advances in the medical therapy of congestive heart failure have changed heart transplantation from an “operation” to a definitive therapy among competing therapies ...